Mendez-Abad et al. examined the potential predictive value of NT-proBNP in preterm infants that will eventually develop BPD, revealing that the assessment of the biomarker at 14 days of life had an even better performance with a sensitivity of 100% and a specificity of 86% [19]. The gene discussed is NPPB; the disease is bronchopulmonary dysplasia.